AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 207 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $187,000 | +139.7% | 16,178 | +108.5% | 0.00% | – |
| Q2 2019 | $78,000 | -46.6% | 7,761 | -29.7% | 0.00% | -100.0% |
| Q4 2017 | $146,000 | -26.3% | 11,032 | +2.8% | 0.00% | 0.0% |
| Q3 2017 | $198,000 | -14.7% | 10,730 | +4.2% | 0.00% | -50.0% |
| Q1 2017 | $232,000 | -49.9% | 10,296 | -22.6% | 0.00% | -50.0% |
| Q4 2016 | $463,000 | +103.1% | 13,306 | +42.7% | 0.00% | +100.0% |
| Q3 2016 | $228,000 | +2.7% | 9,322 | +189.7% | 0.00% | 0.0% |
| Q2 2015 | $222,000 | – | 3,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |